Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Ischemic Heart Disease

Free Subscription Articles published in Ann Intern Med Retrieve available abstracts of 45 articles: HTML format

Single Articles

September 2022
1. CHEW DS, Whitelaw S, Vaduganathan M, Mark DB, et al
   Patient-Reported Outcomes Measures in Cardiovascular Disease: An Evidence Map of the Psychometric Properties of Health Status Instruments.
   Ann Intern Med. 2022 Sep 20. doi: 10.7326/M22-2234.
   PubMed     Abstract available
   
   
   August 2022
2. INOUE-CHOI M, Ramirez Y, Cornelis MC, Berrington de Gonzalez A, et al
   Tea Consumption and All-Cause and Cause-Specific Mortality in the UK Biobank : A Prospective Cohort Study.
   Ann Intern Med. 2022 Aug 30. doi: 10.7326/M22-0041.
   PubMed     Abstract available
   
   
   
3. BOTTON J, Jabagi MJ, Bertrand M, Baricault B, et al
   Risk for Myocardial Infarction, Stroke, and Pulmonary Embolism Following COVID-19 Vaccines in Adults Younger Than 75 Years in France.
   Ann Intern Med. 2022 Aug 23. doi: 10.7326/M22-0988.
   PubMed     Abstract available
   
   
   July 2022
4. KIRSCHNER JM, Hunter BR
   In intermediate-risk stable chest pain, treatment guided by initial CT vs. ICA did not differ for MACE at 3.5 y.
   Ann Intern Med. 2022 Jul 5. doi: 10.7326/J22-0047.
   PubMed     Abstract available
   
   
   June 2022
5. SMETANA GW, Benson MD, Juraschek SP, Burns RB, et al
   Would You Recommend a Statin to This Patient for Primary Prevention of Cardiovascular Disease? : Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
   Ann Intern Med. 2022 Jun 14. doi: 10.7326/M22-0908.
   PubMed     Abstract available
   
   
   May 2022
6. SHIN H, Schneeweiss S, Glynn RJ, Patorno E, et al
   Cardiovascular Outcomes in Patients Initiating First-Line Treatment of Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors Versus Metformin : A Cohort Study.
   Ann Intern Med. 2022 May 24. doi: 10.7326/M21-4012.
   PubMed     Abstract available
   
   
   
7. 
   Summary for Patients: Risk for Heart Attack After Eye Procedures.
   Ann Intern Med. 2022;175:I22.
   PubMed    
   
   
   April 2022
8. HOLT A, Blanche P, Jensen AKG, Nouhravesh N, et al
   Adverse Events Associated With Coprescription of Phosphodiesterase Type 5 Inhibitors and Oral Organic Nitrates in Male Patients With Ischemic Heart Disease : A Case-Crossover Study.
   Ann Intern Med. 2022 Apr 19. doi: 10.7326/M21-3445.
   PubMed     Abstract available
   
   
   
9. 
   Summary for Patients: Risk for Unwanted Outcomes in Men Prescribed Both Drugs for Erectile Dysfunction and Nitrates for Angina.
   Ann Intern Med. 2022 Apr 19. doi: 10.7326/P22-0006.
   PubMed    
   
   
   March 2022
10. SEN A, Gemes K, Stalhammar G, Svensen C, et al
    Risk for Acute Myocardial Infarction After Ophthalmologic Procedures.
    Ann Intern Med. 2022 Mar 22. doi: 10.7326/M20-6618.
    PubMed     Abstract available
    
    
    
11. MURPHY E, McEvoy JW
    Does Stopping Aspirin Differ Fundamentally From Not Starting Aspirin in the Primary Prevention of Cardiovascular Disease Among Older Adults?
    Ann Intern Med. 2022 Mar 15. doi: 10.7326/M22-0550.
    PubMed    
    
    
    
12. SILVESTRI EG, Borzak S
    In patients with MI or high-risk coronary disease, influenza vaccination reduced CV events at 12 mo.
    Ann Intern Med. 2022 Mar 1. doi: 10.7326/J22-0006.
    PubMed     Abstract available
    
    
    
13. BACH RG
    DAPT de-escalation from ticagrelor to clopidogrel 1 mo after PCI for acute MI reduced net clinical events at 1 y.
    Ann Intern Med. 2022;175:JC27.
    PubMed     Abstract available
    
    
    February 2022
14. LARDARO T, Hunter BR
    In suspected or provisionally diagnosed ACS, early CTCA did not reduce mortality or nonfatal MI at 1 y.
    Ann Intern Med. 2022;175:JC20.
    PubMed     Abstract available
    
    
    January 2022
15. PATORNO E, Htoo PT, Everett BM, Kim SC, et al
    Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists and the Risk for Cardiovascular Outcomes in Routine Care Patients With Diabetes Across Categories of Cardiovascular Disease.
    Ann Intern Med. 2022;175:W4.
    PubMed    
    
    
    
16. PATORNO E, Htoo PT, Glynn RJ, Schneeweiss S, et al
    Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists and the Risk for Cardiovascular Outcomes in Routine Care Patients With Diabetes Across Categories of Cardiovascular Disease.
    Ann Intern Med. 2022;175:W4-W5.
    PubMed    
    
    
    
17. BEPO L, Makam AN, Nguyen OK
    Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists and the Risk for Cardiovascular Outcomes in Routine Care Patients With Diabetes Across Categories of Cardiovascular Disease.
    Ann Intern Med. 2022;175:W3.
    PubMed    
    
    
    
18. QIU M
    Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists and the Risk for Cardiovascular Outcomes in Routine Care Patients With Diabetes Across Categories of Cardiovascular Disease.
    Ann Intern Med. 2022;175:W3-W4.
    PubMed    
    
    
    December 2021
19. YEAP BB, Marriott RJ, Antonio L, Raj S, et al
    Associations of Serum Testosterone and Sex Hormone-Binding Globulin With Incident Cardiovascular Events in Middle-Aged to Older Men.
    Ann Intern Med. 2021 Dec 28. doi: 10.7326/M21-0551.
    PubMed     Abstract available
    
    
    
20. ZHAO D, Guallar E
    Testosterone and Cardiovascular Disease in Men.
    Ann Intern Med. 2021 Dec 28. doi: 10.7326/M21-4777.
    PubMed    
    
    
    
21. KANNER L, Glatt AE
    Patients with COVID-19 had increased risk for acute MI and ischemic stroke at 14 d vs. matched controls.
    Ann Intern Med. 2021 Dec 7. doi: 10.7326/ACPJ202112210.
    PubMed     Abstract available
    
    
    
22. CENTOR RM, Patorno E
    Annals On Call - SGLT2 Versus GLP1 for Cardiovascular Prevention.
    Ann Intern Med. 2021;174:OC1.
    PubMed    
    
    
    
23. MURRAY H, Petrie C
    In suspected ACS, an unmasked 0/1-h vs. masked 0/3-h hs-cTnT protocol did not differ for death or MI at 1 y.
    Ann Intern Med. 2021;174:JC139.
    PubMed     Abstract available
    
    
    
24. FAWZY AM, Lip GYH
    In ACS, de-escalation of DAPT reduces bleeding and does not increase ischemic events vs. other DAPT strategies.
    Ann Intern Med. 2021;174:JC138.
    PubMed     Abstract available
    
    
    November 2021
25. CHIANG CH, Chiang CH, Pickering JW, Stoyanov KM, et al
    Performance of the European Society of Cardiology 0/1-Hour, 0/2-Hour, and 0/3-Hour Algorithms for Rapid Triage of Acute Myocardial Infarction : An International Collaborative Meta-analysis.
    Ann Intern Med. 2021 Nov 23. doi: 10.7326/M21-1499.
    PubMed     Abstract available
    
    
    October 2021
26. BURNS RB, Pignone M, Michos ED, Kanjee Z, et al
    Would You Recommend Aspirin to This Patient for Primary Prevention of Atherosclerotic Cardiovascular Disease? : Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
    Ann Intern Med. 2021 Oct 12. doi: 10.7326/M21-2596.
    PubMed     Abstract available
    
    
    September 2021
27. PATORNO E, Htoo PT, Glynn RJ, Schneeweiss S, et al
    Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists and the Risk for Cardiovascular Outcomes in Routine Care Patients With Diabetes Across Categories of Cardiovascular Disease.
    Ann Intern Med. 2021 Sep 28. doi: 10.7326/M21-0893.
    PubMed     Abstract available
    
    
    July 2021
28. JIANG D, Garcia D
    In patients with AMI and anemia, a restrictive vs. liberal blood transfusion strategy was noninferior for 30-d MACE.
    Ann Intern Med. 2021 Jul 6. doi: 10.7326/ACPJ202107200.
    PubMed     Abstract available
    
    
    June 2021
29. TANNER M
    In type 2 diabetes, SGLT2 inhibitors reduce all-cause, but not cardiovascular, mortality vs. GLP-1 RAs.
    Ann Intern Med. 2021 Jun 1. doi: 10.7326/ACPJ202106150.
    PubMed     Abstract available
    
    
    April 2021
30. NEWTON SL, Yeh JS
    Acute Cardiovascular Events Associated With Influenza in Hospitalized Adults.
    Ann Intern Med. 2021;174:582-583.
    PubMed    
    
    
    
31. CHOW EJ, O'Halloran A, Rolfes MA, Reed C, et al
    Acute Cardiovascular Events Associated With Influenza in Hospitalized Adults.
    Ann Intern Med. 2021;174:583-584.
    PubMed    
    
    
    
32. SCHATTNER A
    Acute Cardiovascular Events Associated With Influenza in Hospitalized Adults.
    Ann Intern Med. 2021;174:583.
    PubMed    
    
    
    March 2021
33. NANNA MG, Newby LK
    In coronary artery disease, PCI increases all-cause and cause-specific mortality compared with CABG.
    Ann Intern Med. 2021 Mar 2. doi: 10.7326/ACPJ202103160.
    PubMed     Abstract available
    
    
    
34. BATES ER
    In patients with CAD, adding colchicine to evidence-based therapies reduces MACE without increasing adverse outcomes.
    Ann Intern Med. 2021;174:JC30.
    PubMed     Abstract available
    
    
    
35. GIANNASI G, Nanni V, Nucci A, Perini AP, et al
    Acute ST-Segment Elevation From an Ingested Battery: A Case Report.
    Ann Intern Med. 2021;174:425-426.
    PubMed    
    
    
    January 2021
36. COHN JN
    Low-dose colchicine reduced risk for cardiovascular events in chronic coronary disease.
    Ann Intern Med. 2021 Jan 5. doi: 10.7326/ACPJ202101190.
    PubMed     Abstract available
    
    
    December 2020
37. HICKS CW, Wang D, Matsushita K, Windham BG, et al
    Peripheral Neuropathy and All-Cause and Cardiovascular Mortality in U.S. Adults : A Prospective Cohort Study.
    Ann Intern Med. 2020 Dec 8. doi: 10.7326/M20-1340.
    PubMed     Abstract available
    
    
    October 2020
38. BAVISHI C
    In ACS treated with drug-eluting stents and 3 mo of DAPT, ticagrelor monotherapy reduced clinical events at 1 y vs. DAPT.
    Ann Intern Med. 2020;173:JC43.
    PubMed     Abstract available
    
    
    
39. NANNA MG, Granger CB
    In ACS, ticagrelor and prasugrel each reduce some ischemic events but increase major bleeding vs. clopidogrel.
    Ann Intern Med. 2020;173:JC44.
    PubMed     Abstract available
    
    
    September 2020
40. RESTON JT, Buelt A, Donahue MP, Neubauer B, et al
    Interventions to Improve Statin Tolerance and Adherence in Patients at Risk for Cardiovascular Disease : A Systematic Review for the 2020 U.S. Department of Veterans Affairs and U.S. Department of Defense Guidelines for Management of Dyslipidemia.
    Ann Intern Med. 2020 Sep 22. doi: 10.7326/M20-4680.
    PubMed     Abstract available
    
    
    
41. O'MALLEY PG, Arnold MJ, Kelley C, Spacek L, et al
    Management of Dyslipidemia for Cardiovascular Disease Risk Reduction: Synopsis of the 2020 Updated U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline.
    Ann Intern Med. 2020 Sep 22. doi: 10.7326/M20-4648.
    PubMed     Abstract available
    
    
    
42. KELSEY MD, Newby LK
    In older patients with NSTE-ACS, clopidogrel safely reduced bleeding compared with ticagrelor at 1 year.
    Ann Intern Med. 2020;173:JC28.
    PubMed     Abstract available
    
    
    
43. HOFFER EP
    In AF with recent ACS or PCI, apixaban improved 30-day outcomes vs. VKAs; aspirin effects varied vs. placebo.
    Ann Intern Med. 2020;173:JC29.
    PubMed     Abstract available
    
    
    
44. ELGENDY IY
    In ACS, prasugrel reduces 30-day MACE and mortality vs. ticagrelor or clopidogrel; no differences for major bleeding.
    Ann Intern Med. 2020;173:JC27.
    PubMed     Abstract available
    
    
    June 2020
45. MURRAY H, Slaunwhite E
    Accelerated diagnostic algorithms with hs-cTn have >/= 92% sensitivity but lower specificity for diagnosing AMI.
    Ann Intern Med. 2020;172:JC71.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: